Résumé
This is a Horizon Europe recognition prize call under the EDCTP3 (European & Developing Countries Clinical Trials Partnership) joint undertaking for 2026. The call supports scientific leadership in global health research, with a specific application deadline of 2 September 2026. No budget, participation requirements, or detailed eligibility criteria are stated in the provided information.
Analyse d'adéquation
This is a recognition prize for scientific leadership in the EDCTP (European & Developing Countries Clinical Trials Partnership) domain, which focuses on clinical trials and infectious diseases in developing countries—entirely outside Acme Corporation's semiconductor and AI focus. The company is ineligible as it is a commercial semiconductor/AI firm, not a research institution or university, and the call's thematic scope has no connection to the client's strategic priorities.
Scores détaillés
Brief exécutif
LowPas d'analyse approfondie — ce score ≤ 6,0 n'a pas déclenché l'analyse détaillée. Voir l'analyse d'adéquation ci-dessus.
Description
HORIZON Recognition Prize Call: HORIZON-JU-EDCTP3-2026-SCILEADERSHIPMANEUPRIZE Programme period: 2021 - 2027